journal article·2024-12Open access

99mTc/90Y radiolabeled biodegradable gel microspheres for lung shutting fraction assessment and radioembolization in hepatocellular carcinoma theranostics

Yi Dong, Lingling Yin, Jintao Huang, Di Hu, Jing Sun, Zhe Zhang, Zhihao Li, Bin-Yan Zhong, Ran Zhu, Guanglin Wang

Abstract

Transarterial radioembolization (TARE) is a well-established clinical therapy for the treatment of patients with intermediate to advanced hepatocellular carcinoma (HCC) or those who are ineligible for radical treatment. However, commercialized radioactive microspheres still have some issues, such as high density, complicated preparation, non-biodegradability. Furthermore, the use of different radioactive microspheres during TARE and lung shunt fraction assessment has led to inconsistencies in biodistribution in certain cases. This study employed biodegradable hyaluronic acid (HA) as the backbone and modified with bisphosphonate and methacrylic acid to prepare biodegradable gel microspheres (HAMS) using the water-in-oil emulsification and photo-crosslinking for labeling the diagnostic radionuclide of 99m Tc and therapeutic radionuclide of 90 Y. Both 99m Tc radiolabeled HAMS ( 99m Tc-HAMS) and radiolabeled 90 Y-HAMS ( 90 Y-HAMS) were highly efficient in radiolabeling and exhibited excellent radiostability in vitro and in vivo . 99m Tc-HAMS are highly effective in assessing the LSF, while 90 Y-HAMS, administered though TARE, are effective in inhibiting the growth of in situ HCC without any side effects. Both 99m Tc-HAMS and 90 Y-HAMS have promising clinical applications in HCC theranostics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hepatocellular Carcinoma Treatment and Prognosis · Radiomics and Machine Learning in Medical Imaging · Medical Imaging and Pathology Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Hepatocellular carcinoma10.1016/S0140-6736(22)01200-4 ↗
2. Systemic treatment for advanced hepatocellular carcinoma10.1159/000496439 ↗
3. Interventional treatment of hepatocellular carcinoma10.1016/j.jhep.2022.03.037 ↗
4. Systemic treatment options in hepatocellular carcinoma10.1159/000499765 ↗
5. Treatment of liver cancer10.1001/jama.2015.15431 ↗
6. Radioactive drugs emerge from the shadows to storm the market10.1038/nbt1218-1125 ↗
7. Transarterial chemoembolization and radioembolization10.1055/s-0034-1394142 ↗
8. Engineering radioactive microspheres for intra-arterial brachytherapy using radiation-induced graft polymerization10.1002/adfm.202306215 ↗
9. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma10.1038/s41575-020-00395-0 ↗
10. 131I-labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization10.7150/thno.21491 ↗
11. Facile preparation of 177Lu-microspheres for hepatocellular carcinoma radioisotope therapy10.1016/j.cclet.2022.01.007 ↗
12. Polydopamine-coated radiolabeled microspheres for combinatorial radioembolization and photothermal cancer therapy10.1021/acsami.2c19829 ↗
13. The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer10.1016/j.apsb.2018.04.001 ↗
14. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group
15. Surface characteristics of holmium-loaded poly (l-lactic acid) microspheres10.1016/j.biomaterials.2004.03.028 ↗
16. Influence of neutron irradiation on holmium acetylacetonate loaded poly (l-lactic acid) microspheres10.1016/S0142-9612(01)00309-X ↗
17. Personalized dosimetry for liver cancer Y-90 radioembolization using computational fluid dynamics and Monte Carlo simulation10.1007/s10439-020-02469-1 ↗
18. Radioactive holmium phosphate microspheres for cancer treatment10.1016/j.ijpharm.2018.06.036 ↗
19. Same-day repeat hepatopulmonary shunt measurement during planning angiography for hepatic radioembolization10.1016/j.jvir.2020.03.006 ↗
20. Systematic review of lung shunt fraction quantification comparing SPECT/CT and planar scintigraphy for yttrium 90 radioembolization planning10.1007/s40336-021-00417-0 ↗
21. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment10.2967/jnumed.109.074559 ↗
22. From the angio suite to the γ-camera: vascular mapping and 99mTc-MAA hepatic perfusion imaging before liver radioembolization - a comprehensive pictorial review10.2967/jnumed.112.105361 ↗
23. An effective translation: the development of hyaluronan-based medical products from the physicochemical, and preclinical aspects10.3389/fbioe.2018.00062 ↗
24. The degradation of hyaluronan in the skin10.3390/biom12020251 ↗
25. Hyaluronic acid and albumin based nanoparticles for drug delivery10.1016/j.jconrel.2021.01.033 ↗
26. Microfluidic electrospray of multifunctional discal microparticles for wound healing10.1021/acsmaterialslett.3c01182 ↗
27. Mouse liver lysosomes contain enzymatically active processed forms of Hyal-110.1016/j.bbrc.2014.03.070 ↗
28. Subcellular trafficking and activity of Hyal-1 and its processed forms in murine macrophages10.1111/tra.12162 ↗
29. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion10.1074/jbc.M311838200 ↗
30. The many ways to cleave hyaluronan10.1016/j.biotechadv.2007.07.001 ↗
31. Universal strategy for designing shape memory hydrogels10.1021/acsmaterialslett.2c00107 ↗
32. Biomacromolecules as carriers in drug delivery and tissue engineering10.1016/j.apsb.2017.11.005 ↗
33. On-site fabrication of injectable 131I-labeled microgels for local radiotherapy10.1016/j.jconrel.2020.03.046 ↗
34. Microfluidic fabrication of X-ray-visible sodium hyaluronate microspheres for embolization10.1039/D3RA02812G ↗
35. Microfluidic controllable preparation of iodine-131-labeled microspheres for radioembolization therapy of liver tumors10.1002/adhm.202300873 ↗
36. Biodegradable radiofrequency responsive nanoparticles for augmented thermal ablation combined with triggered drug release in liver tumors10.1021/acsbiomaterials.5b00511 ↗
37. Radioembolization of hepatocellular carcinoma with built-in dosimetry: First in vivo results with uniformly-sized, biodegradable microspheres labeled with 188Re10.7150/thno.29381 ↗
38. Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres: a radiolabeling and stability study10.1016/j.nucmedbio.2007.04.003 ↗
39. Phosphonates, their complexes and bio-applications: a spectrum of surprising diversity10.1016/j.ccr.2011.07.002 ↗
40. Modification of hyaluronic acid to enable click chemistry photo-crosslinking of hydrogels with tailorable degradation profiles10.1016/j.ijbiomac.2023.124459 ↗
41. Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies10.1016/j.ijbiomac.2019.11.066 ↗
42. Characteristic and chondrogenic differentiation analysis of hybrid hydrogels comprised of hyaluronic acid methacryloyl (HAMA), gelatin methacryloyl (GelMA), and the acrylate-functionalized nano-silica crosslinker10.3390/polym14102003 ↗
43. Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies10.1007/s00259-018-3968-5 ↗
44. Targeted design of a recombinant tracer for SPECT renal imaging10.7150/thno.60132 ↗
45. Applications of yttrium-90 (90Y) in hepatocellular carcinoma10.2147/OTT.S445898 ↗
46. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus10.21037/jgo.2017.09.10 ↗
47. A picture of modern 99mTc radiopharmaceuticals: production, chemistry, and applications in molecular imaging10.3390/app9122526 ↗
48. Natural product-based radiopharmaceuticals: focus on curcumin and its analogs, flavonoids, and marine peptides10.1016/j.jpha.2021.07.006 ↗
49. Procoagulant CaCO3-embedded embolic microspheres can potentiate transcatheter arterial embolization of hepatocellular carcinoma10.1016/j.nantod.2024.102216 ↗
50. Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours10.1007/s00259-013-2550-4 ↗
51. On-demand degradable embolic microspheres for immediate restoration of blood flow during image-guided embolization procedures10.1016/j.biomaterials.2020.120408 ↗
52. On-site fabrication of injectable 131I-labeled microgels for local radiotherapy10.1016/j.jconrel.2020.03.046 ↗
53. Liver enzyme alteration: a guide for clinicians10.1503/cmaj.1040752 ↗